Avalo Therapeutics Inc
F:C6K
Avalo Therapeutics Inc
F:C6K
Price:
2.488
EUR
3.15%
Market Closed
Market Cap:
€238.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Avalo Therapeutics Inc
F:C6K
|
US |
|
LendLease Group
ASX:LLC
|
AU |
|
A
|
Aurania Resources Ltd
F:20Q
|
CA |
Wall St Price Targets
C6K Price Targets Summary
Avalo Therapeutics Inc
Avalo Therapeutics Inc
Wall Street analysts forecast C6K stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for C6K is 7.478 EUR with a low forecast of 5.514 EUR and a high forecast of 10.155 EUR.
Lowest Forecast
Price Target
5.514
EUR
122% Upside
Average Forecast
Price Target
7.478
EUR
201% Upside
Highest Forecast
Price Target
10.155
EUR
308% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is C6K's stock price target?
Price Target
7.478
EUR
7.478
EUR
According to Wall Street analysts, the average 1-year price target for C6K is 7.478 EUR with a low forecast of 5.514 EUR and a high forecast of 10.155 EUR.
What is the Revenue forecast for Avalo Therapeutics Inc?
Projected CAGR
227%
227%
Over the last 13 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 8 years is 227%.
